difficult
thing
futur
hard
predict
second
world
war
avail
vaccin
antibiot
success
improv
hygien
public
health
polici
led
dramat
fall
mortal
us
surgeon
gener
claim
close
book
infecti
diseas
hindsight
predict
futur
utterli
wronginfecti
diseas
back
vengeanc
nearli
annual
death
worldwid
directli
relat
pathogen
moren
et
al
multidrugresist
tuberculosi
hivaid
rise
worldwid
staphylococcu
enterococcu
strain
western
hospit
becom
increasingli
resist
antibiot
addit
rapid
spread
new
pathogen
sar
sever
acut
respiratori
syndrom
west
nile
virus
shown
frailti
global
public
health
affect
tourism
trade
expert
secur
public
health
also
worri
publicli
avail
scientif
inform
advanc
genet
technolog
could
misus
creat
weapon
bioterror
overcom
threat
human
health
research
pathogen
microb
develop
new
diagnost
vaccin
therapeut
strategi
remain
import
task
begin
twentyfirst
centuri
context
conduct
foresight
studi
futur
trend
challeng
pathogenom
part
eufund
eranet
project
pathogenom
provid
overview
current
futur
trend
challeng
field
genom
research
pathogen
microorgan
clearli
foresight
studi
crystal
ball
peek
futur
allow
identif
import
trend
scienc
well
perceiv
gap
research
place
context
futur
challeng
public
health
pursu
dual
approach
conduct
survey
nation
intern
expert
field
pathogenom
extens
literatur
research
survey
develop
questionnair
email
expert
research
humanpathogen
microorgan
relat
field
receiv
repli
complet
questionnair
overal
repli
rate
return
rate
satisfactori
comley
totten
sheehan
literatur
review
use
academ
search
engin
direct
access
scientif
journal
search
conduct
use
follow
keyword
combin
term
pathogenom
infecti
diseas
public
health
bacteria
fungi
bioweapon
bioterror
human
pathogen
result
hit
select
review
articl
abstract
press
releas
analys
trend
challeng
research
threat
public
health
current
bottleneck
commerci
drug
vaccin
develop
ne
clear
trend
accord
weinstock
studi
pathogen
microorgan
undergo
major
chang
trigger
avail
whole
genom
sequenc
new
screen
technolog
proteom
compar
genom
bioinformat
technolog
combin
convent
method
serolog
cultiv
strain
becom
increasingli
import
classif
evolutionari
analysi
microorgan
lederberg
molecular
fingerprint
singlenucleotid
polymorph
analys
molecular
epidemiolog
allow
studi
molecular
process
infect
includ
inflamm
host
immun
respons
function
cellsurfac
protein
bacteri
secret
system
vivo
express
analys
new
bioimag
techniqu
measur
gene
express
protein
transport
enabl
scientist
investig
role
develop
basic
research
put
context
current
futur
challeng
public
health
diseas
longer
seen
problem
develop
countri
global
trade
tourism
enabl
rapid
distribut
infecti
organ
v
iew
point
individu
gene
infect
real
time
doyl
et
al
technolog
advanc
applic
microbiolog
contribut
better
understand
hostmicrob
interact
immun
respons
molecular
physiolog
level
accord
hatful
jacob
also
much
progress
studi
genet
infect
pathogenesi
well
commun
microorgan
much
need
known
parsek
fuqua
highlight
import
research
surfaceassoci
pathogen
biofilm
plankton
cultur
far
neglect
knowledg
help
research
understand
complex
interact
microb
wherea
model
stress
factor
environ
elucid
interact
microb
host
factor
context
identif
virul
factor
secret
effector
modul
human
immun
system
exotoxin
small
molecul
extracellular
enzym
anoth
import
goal
meet
increas
problem
antibiot
resist
basic
research
also
concentr
detect
analysi
mobil
pathogen
element
resist
transfer
genom
island
hacker
carniel
anoth
import
develop
fusion
cell
biolog
microbiolog
great
import
studi
situ
express
gene
roux
et
al
den
colleagu
note
recent
advanc
microscopi
multidimension
imag
laserscan
microscopi
epifluoresc
microscopi
fluoresc
lightbas
imag
stress
import
microscopi
histopatholog
need
better
cooper
basic
clinic
research
particularli
collect
epidemiolog
data
devis
new
effici
therapi
also
relat
concern
nanobiotechnolog
also
gain
import
analyt
approach
chip
technolog
system
biolog
analysi
experiment
data
see
sidebar
titl
import
challeng
basic
research
gener
new
technolog
need
understand
clearli
natur
infect
devis
new
strategi
infecti
organ
import
goal
identif
specif
target
gene
dna
chip
use
clinic
diagnost
develop
new
antibiot
vaccin
accord
weinstock
discoveri
target
gene
major
problem
rather
develop
highthroughput
method
test
efficaci
new
therapeut
furthermor
forecast
candid
gene
identifi
commerci
use
long
scientist
abl
understand
fulli
molecular
mechan
infect
pathogenesi
nother
import
research
area
particularli
light
new
reemerg
diseas
concern
dynam
microb
popul
effect
environment
factor
popul
includ
natur
reservoir
pathogen
geograph
distribut
differenti
generalist
specialist
among
humanpathogen
agent
microbeenviron
interact
cleaveland
et
al
accord
woolhous
colleagu
popul
biolog
explain
evolutionari
dynam
pathogen
special
stress
respons
microb
woolhous
also
emphas
import
studi
rout
pathogen
transmiss
vector
arthropod
direct
exampl
physic
contact
indirect
contact
food
ultim
epidemiolog
research
contribut
earli
identif
novel
reemerg
diseas
caus
bacteria
fungi
multiresist
bacteri
strain
context
understand
immun
select
impact
vaccin
antibiot
intervent
microbi
popul
futur
challeng
research
grenfel
et
al
far
studi
mostli
use
pure
bacteri
cultur
cours
reflect
realiti
delong
therefor
stress
need
microbi
popul
genom
character
uncultivat
bacteri
fungal
speci
interact
variou
microbi
popul
also
mani
aspect
medic
system
pose
threat
public
health
import
cleaveland
colleagu
identifi
speci
organ
known
pathogen
human
includ
bacteria
rickettsia
fungi
accord
rappuoli
dozen
new
infecti
diseas
expect
emerg
come
decad
virus
particularli
rna
virus
seem
emerg
rapidli
context
lederberg
stress
need
understand
evolutionari
strategi
pathogen
microb
facilit
reemerg
emerg
new
unknown
pathogen
due
rapid
reproduct
enorm
potenti
genet
variat
mutat
genet
variat
recombin
horizont
gene
transfer
pathogen
island
key
evolut
pathogen
hacker
carniel
still
understood
f
cours
trend
develop
basic
research
put
context
current
futur
challeng
public
health
see
sidebar
titl
challeng
interdisciplinari
research
humanpathogen
microorgan
encompass
demograph
chang
age
popul
effect
global
popul
growth
migrationwhos
social
ecolog
econom
factor
interplay
still
poorli
understood
pang
guindon
expert
survey
identifi
hiv
spread
multidrugresist
tuberculosi
eastern
europ
major
problem
public
healthsom
expert
estim
onethird
world
infect
mycobacterium
tuberculosi
fauci
et
al
problem
mention
expert
survey
includ
malaria
sar
monkey
pox
sexual
transmit
respiratori
diarrhoeal
diseas
greatest
challeng
chan
colleagu
describ
substanti
differ
develop
develop
countri
respect
burden
infecti
diseas
author
estim
popul
develop
world
infect
least
one
pathogen
organ
compar
develop
world
mani
develop
countri
socioeconom
factor
poverti
crowd
poor
hygien
repres
major
risk
transmiss
infecti
diseas
accordingli
global
public
health
wilson
manmad
ecolog
chang
deforest
pollut
effect
land
use
water
storag
also
influenc
biolog
divers
distribut
parasit
infecti
diseas
guernier
et
al
chan
colleagu
estim
global
climat
condit
particular
import
determin
pathogen
distribut
far
studi
phenomenon
avail
irrespect
global
climat
condit
simpl
weather
chang
influenc
emerg
infecti
diseas
vector
sutherst
exampl
el
phenomenon
southern
pacif
flood
caus
outbreak
malaria
waterborn
diseas
cholera
moren
et
al
altekrus
colleagu
therefor
identifi
foodborn
waterborn
diseas
major
threat
public
health
moren
colleagu
also
describ
increas
zoonot
vectorborn
diseas
due
environment
factor
recent
manmad
intervent
trend
acceler
antibiot
overus
agricultur
may
increas
prolifer
bacteri
fungal
diseas
rapid
spread
sar
china
rest
world
show
infecti
diseas
longer
seen
problem
develop
countri
global
trade
tourism
enabl
rapid
distribut
infecti
organ
mangili
gendreau
thu
predict
increas
airborn
foodborn
vectorborn
zoonot
diseas
caus
increas
eas
afford
air
travel
cleaveland
colleagu
therefor
stress
human
behaviour
main
factor
spread
infecti
diseas
also
mani
aspect
medic
system
pose
threat
public
health
import
problem
lack
hygien
hospit
result
increas
socal
nosocomi
hospitalacquir
diseas
burk
new
technolog
transplant
medicin
immunosuppress
therapi
prosthet
devic
also
rais
preval
chronic
polymicrobi
infect
donlan
costerton
increas
number
brogden
et
al
death
caus
mycos
mcneil
et
al
taken
serious
problem
publichealth
system
includ
decreas
number
effect
antibiot
insuffici
guidelin
surveil
method
antibiot
resist
gener
decreas
research
antiinfect
den
et
al
lederberg
critic
especi
misus
antibiot
popular
antibacteri
product
contribut
spread
multidrug
antimicrobi
resist
goossen
et
al
particularli
among
mycobacterium
tuberculosi
staphylococcu
aureu
methicillinresist
aureu
vancomycinresist
enterococci
drugresist
gramneg
bacteria
klebsiella
enterobact
spp
alreadi
becom
major
problem
mani
hospit
set
levi
kipp
et
al
led
car
nordberg
specul
possibl
postantibiot
era
final
potenti
misus
scientif
inform
genet
engin
bioterror
biowarfar
worri
public
health
secur
expert
may
silverman
remain
seen
whether
freeli
avail
inform
genet
genom
research
suffici
develop
biolog
weapon
rappert
world
health
organ
geneva
switzerland
accordingli
address
need
action
plan
counteract
potenti
bioterrorist
attack
inde
woodal
critic
intern
bodi
investig
sudden
emerg
infecti
diseas
p
redominantli
need
prevent
reemerg
infecti
diseas
turn
epidem
pandem
global
surveil
network
vaccin
strategi
mabey
et
al
especi
childhood
immun
breiman
develop
develop
countri
must
therefor
increas
particip
rate
vaccin
programm
improv
health
educ
public
polici
addit
gener
measur
cangelosi
colleagu
recommend
effect
monitor
pathogen
environ
would
allow
research
understand
incid
persist
regard
novel
infecti
diseas
guillemot
colleagu
address
identif
natur
sourc
zoonot
reservoir
basi
prevent
control
outbreak
accord
enserink
better
coordin
lab
public
health
organ
global
alert
network
global
outbreak
alert
respons
network
goarn
would
lead
earlier
identif
novel
pathogen
educ
sanit
water
suppli
develop
countri
must
improv
counteract
increas
internation
health
risk
brought
infecti
diseas
pang
guindon
us
nation
institut
allergi
infecti
diseas
bethesda
md
usa
niaid
stress
need
food
safeti
animalcontrol
programm
clean
water
sewer
mani
gastrointestin
pathogen
transmit
water
moreov
essenti
develop
compar
riskassess
strategi
set
nation
global
health
prioriti
murray
et
al
forecast
system
computermodel
techniqu
diseas
epidemiolog
measur
assess
impact
diseas
outbreak
hampton
f
rom
perspect
basic
research
identif
factor
lead
chronic
secondari
diseas
evolut
antibiot
resist
fundament
challeng
cassel
mekalano
practic
level
rapid
sensit
robust
diagnost
tool
need
addit
improv
diseasemanag
strategi
infrastructur
part
earli
respons
strategi
tackl
infecti
diseas
howev
replac
imper
develop
new
antibiot
make
better
use
exist
one
accord
bonhoeff
colleagu
altern
differ
antibiot
evalu
singl
multipl
antibiot
therapi
ration
use
antibiot
gener
necessari
reduc
bacteri
resist
although
develop
new
antibiot
vaccin
remain
import
publichealth
imper
pharmaceut
compani
littl
interest
research
area
european
feder
pharmaceut
industri
associ
efpia
brussel
belgium
note
european
industri
undergo
radic
chang
past
decad
trigger
increas
cost
r
market
efpia
led
rise
number
compani
merger
takeov
greater
focu
drug
treat
chronic
abund
diseas
mainli
affluent
popul
develop
new
antibiot
vaccin
long
costli
process
ultim
find
limit
market
william
heymann
research
area
attract
mani
pharmaceut
compani
spellberg
colleagu
stress
drug
latestag
clinic
test
six
new
antibacteri
similarli
small
number
biotech
compani
develop
vaccin
antifung
drug
bonn
nevertheless
promis
commerci
attract
area
research
antiinfect
vaccin
sheridan
instanc
describ
innov
approach
use
recombin
dna
techniqu
develop
new
vaccin
combin
vaccin
prevent
complex
syndrom
might
use
along
new
method
vaccin
applic
antibodi
prepar
often
faster
cheaper
vaccin
develop
breiman
casadeval
et
al
also
forecast
rise
market
product
basi
revers
vaccinolog
genet
vaccin
recombin
antigen
conjug
therapeut
vaccin
accord
efpia
outsourc
project
subcontract
smaller
compani
especi
area
preclin
research
toxicolog
analysi
could
render
antibiot
vaccin
develop
suffici
benefici
pharmaceut
biotech
industri
final
cockeril
smith
expect
greater
market
genomicbas
diagnost
screen
technolog
howev
import
step
toward
better
fit
industri
interest
public
health
need
would
cooper
publichealth
author
clinician
affect
commun
pharmaceut
compani
henc
government
support
reduct
administr
barrier
efpia
publicpriv
partnership
advoc
organ
ridley
partnership
small
medium
biotech
compani
new
busi
model
encourag
develop
sensit
robust
diagnost
tool
need
addit
improv
diseasemanag
strategi
infrastructur
part
earli
respons
strategi
tackl
infecti
diseas
educ
sanit
water
suppli
develop
countri
must
improv
counteract
increas
internation
health
risk
brought
infecti
diseas
v
iew
point
new
drug
nathan
need
meet
threat
infecti
diseas
w
e
nowher
near
abl
close
book
infecti
diseas
virus
parasit
bacteria
still
claim
million
live
year
develop
world
even
affluent
nation
reason
remain
complac
effect
global
name
trade
travel
well
domest
problem
increas
antibiot
resist
mean
infecti
diseas
remain
major
problem
develop
world
well
nevertheless
recent
develop
microbiolog
use
new
technolog
provid
genom
proteom
bioinformat
hold
great
promis
understand
microbi
evolut
natur
infecti
process
knowledg
certainli
pave
way
new
therapeut
drug
vaccin
treatment
time
publichealth
author
pharmaceut
biotech
industri
must
find
new
way
encourag
develop
new
therapeut
first
foremost
howev
problem
requir
greater
awar
beyond
scientist
publichealth
expertsit
ultim
societi
politician
support
much
need
measur
global
surveil
research
develop
counter
threat
pose
infecti
diseas
v
iew
point
